Health Robotics Expands i.v.STATION and i.v.SOFT Asia-Pacific Coverage to the Republic of Korea With BioRobotics

By Health Robotics, PRNE
Wednesday, August 11, 2010

BOZEN, Sud-Tirol, Italy, August 12, 2010 - Health Robotics today announced that BioRobotics, on the heels of its
unprecedented market success with its line of Oncology Surgery robots, has
exclusively selected Health Robotics' i.v.STATION Robot and i.v.SOFT Workflow
Engine to complete its objective to become the gold standard for IV
Admixtures Automation in the Republic of Korea, building on top of its
CytoCare exclusive agreement nine months ago.

"Expanding our CytoCare relationship with Health Robotics to these
additional products has been an strategic goal of ours for quite some time,
as we believe that the cost and small footprint of these innovative products
together with their applicability to all Korean acute care hospitals as
opposed to only Cancer Centers gives us the ability to enhance our objective
to maximize market share and to offer end-to-end IV Automation solutions to
our customers in the Republic of Korea", stated Bum Kyo Lee, CEO of
BioRobotics.

i.v.STATION represents a revolutionary approach in the quest for safe,
accurate, efficient, cost effective, and ready-to-administer intravenous
patient doses. It offers unprecedented reduction of medication errors,
ISO-compliant accuracy, improved sterility, and clinician labor savings: all
within a scalable, cost-effective, distributed, and fail-safe architecture.
i.v.SOFT constitutes an ideal complement to CytoCare and i.v.STATION both as
a means to back-up robotic devices and to direct excess IV Admixture
production demand and non-standard IV consumables (i.e. cassette pumps,
ampoules, glass bottles, IV doses requiring the use of CSTDs, etc.) towards
Laminar Airflow Hoods.

"It is a pleasure to renew our commitment and strategic partnership with
BioRobotics and to ship the first i.v.STATION robot to Korea for installation
in December 2010. We are confident that BioRobotics' technical expertise with
Surgery Robots positions them to take full advantage of our new products.
Additionally, this new strategic agreement marks the significant milestone
for Health Robotics of completing mainland Asia marketing and service
channels' coverage for i.v.STATION, with only Taiwan and Oceania channel
strategies remaining to be determined over the next few months", stated
Gaspar DeViedma, Health Robotics' Executive Vice President.

About BioRobotics:

Founded in 1995, BioRobotics is currently the leading medical robotics
supplier and the second largest medical importing business in the Republic of
Korea with US $27M import volume during the year 2008. The company originally
started in the Aesthetic laser surgery and Cryosurgery medical sectors and
further expanded into robotic surgery in 2005. In only 4 years since the
launch of Oncology Robotics in its core market, BioRobotics has already
achieved twenty-four (24) installations of the daVinci(R) Surgical robot in
the Republic of Korea. For more information, please visit:
www.biorobotics.co.kr/

About Health Robotics:

Health Robotics is the undisputed global leading supplier of
life-critical intra-venous medication robots, providing over 100 hospital
installations in 5 continents with robotics technology and software
automation solutions deployed utilizing virtual high-availability technology.
Its world-leading solutions CytoCare(TM) [hazardous IVs], i.v.STATION(TM)
[non-hazardous IVs], i.v.SOFT(TM) [manual compounding software],
MEDarchiver(TM) [life-critical clinical information system], and
TPNstation(TM) [totally-automated parenteral nutrition] have and will greatly
contribute to ease hospitals' growing pressures to improve patient safety,
increase throughput and contain costs. Through the effective and efficient
production of sterile, accurate, tamper-evident and ready-to-administer IVs,
Health Robotics' solutions help hospitals eliminate life-threatening drug and
diluent exchange errors, decrease other medical mistakes and sterility risks,
work more efficiently, reduce waste and controlled substances' diversion, and
diminish the gap between rising patient volume/acuity and scarce medical,
nursing, and pharmacy staff. For more information, please visit:
www.health-robotics.com

    For additional information, please contact:

    Claudia Flaim, Health Robotics' Marketing Coordinator
    Altmanstrasse 9/A, Bozen, I-39100
    flaim@health-robotics.com
    Phone: +39-0471-200-372

    Bum Kyo Lee, BioRobotics' CEO
    5F 5-36 Hyochang-dong, Yongsan-ku, Seoul, Korea
    bk@biorobot.co.kr
    Phone: +82-270-15266

For additional information, please contact: Claudia Flaim, Health Robotics' Marketing Coordinator, Altmanstrasse 9/A, Bozen, I-39100, flaim at health-robotics.com , Phone: +39-0471-200-372. Bum Kyo Lee, BioRobotics' CEO, 5F 5-36 Hyochang-dong, Yongsan-ku, Seoul, Korea, bk at biorobot.co.kr , Phone: +82-270-15266.

YOUR VIEW POINT
NAME : (REQUIRED)
MAIL : (REQUIRED)
will not be displayed
WEBSITE : (OPTIONAL)
YOUR
COMMENT :